Interleukin-32 expression in the pancreas - Wikidata - awgldk - TriplyDB

Interleukin-32 expression in the pancreas

Interleukin-32 expression in the pancreas

http://www.wikidata.org/entity/Q28390023

about

Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.Gene Expressions for Signal Transduction under Acidic Conditions IL-32 promotes angiogenesis.Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.IL-32 promotes breast cancer cell growth and invasiveness Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.IL-32γ delays spontaneous apoptosis of human neutrophils through MCL-1, regulated primarily by the p38 MAPK pathway.Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.The Influence of Bone Marrow-Secreted IL-10 in a Mouse Model of Cerulein-Induced Pancreatic Fibrosis Novel insights into the biology of interleukin-32.IL-32α has differential effects on proliferation and apoptosis of human melanoma cell lines.Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines.Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells.Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.Von Hippel-Lindau regulates interleukin-32β stability in ovarian cancer cells.Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease.Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma.IL-32 expression is an independent prognostic marker for gastric cancer.Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.Regulation and expression of IL-32 in chronic rhinosinusitis.Role of interleukin-32 in cancer biology.Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis.Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens The Biology and Role of Interleukin-32 in Tuberculosis Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus

P2860

Q30411120-90C1BCC5-C9AF-4739-B86C-D2B4BDDB9E1B Q30441262-D778454D-37E0-401B-93C9-FD6E27A7DA76 Q33555523-69BD6CFE-0B0F-4898-9FD7-B897AA7E7462 Q34494032-28C0A0F9-92F1-44D8-9494-B9EF68D6EC9D Q34582585-46011AFD-0A17-4F7D-9FE5-94AD35098544 Q34752043-16032E6C-4FF2-4085-AA63-A42B3BDDB10A Q35134651-62724A58-D3CB-4C0B-BE2A-B9C5227C9CE7 Q35294123-2E2960C8-4A0B-4F54-97AD-EAFF4C3FC5DA Q35551409-E2F83C9A-7D70-48EE-B71D-8AA4DB8BD120 Q35641151-D4646E5B-CDB2-4AE1-AE37-E5A4460ED4EF Q35947673-6E458077-0309-4590-8252-2B73355B0267 Q35995303-65EAFA4B-7798-46E2-8AFE-19BB08866D30 Q36150219-C38A4962-A936-4A47-AE60-C6E4A6813CEE Q36246023-DE255E26-F22A-4017-9300-F6985F82208C Q36318831-B2528648-F8C8-4636-B7AF-54B3F44C167B Q36970134-5755805B-F264-4797-9E51-8420DC1A1AA2 Q38086768-5C056B6F-3DA7-4CDF-9860-4A9A54DAE121 Q38776515-ED12B2A0-30BC-42CC-B211-D32B3E040E67 Q38810990-A6AEE38C-87CF-4A4E-9709-BE1D5ED8CFF9 Q39297849-6A1CC2DF-4067-4020-AFFD-A5ECEAF4C21C Q39611935-9CDD6B4B-5134-4E89-9231-90DE805C4D12 Q40674604-BB5AB4A4-394B-429F-B1FB-CC3A5C5D8E87 Q41495034-002407D1-4C11-433D-BDA8-67FEE81059D7 Q41945018-8AAF757B-AE31-4D5B-9314-6AFC21EF2188 Q42100214-4F49AF79-4D67-4919-8018-AE6F896B7BAE Q42236150-8E9C4BC7-F88A-46F6-A678-39FEDA8C0641 Q42378385-21508150-388F-4A62-82DD-C9D650B87B37 Q43275120-ECB102CC-00F0-4BB1-B9E0-ADFFC69F8DAB Q45405767-8C3F6381-4759-4BD1-8BAA-5F44223244F9 Q46107165-9441B3CB-CA33-4DC5-8743-48DF1A70FB50 Q47158965-46F4CD7A-3500-4F17-A659-A7351FABA84A Q53312855-AA646362-6BD8-4D2D-8BA9-9AC857B770A5 Q53404199-D81F745F-271B-459D-B028-370D53DB2D66 Q54315642-DEA97A17-8FCA-4058-94A3-DD5A8444C190 Q55264916-25566E8C-5DB3-42C2-8207-A5C2EDF5063C Q55435298-604F20C6-F4A8-440C-AF0D-6FE24B77D40E Q58214193-BB3DAEE6-7021-4A53-B57A-908BB5A6E341 Q58694023-8A0B83BB-460B-498B-9D87-A401780D5954 Q58774481-68A67CA0-BDFC-432F-A1CE-5038BE28AA08

P2860

Interleukin-32 expression in the pancreas

http://www.wikidata.org/entity/Q28390023

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Interleukin-32 expression in the pancreas

@ast

Interleukin-32 expression in the pancreas

@en

Interleukin-32 expression in the pancreas

@nl

type

label

Interleukin-32 expression in the pancreas

@ast

Interleukin-32 expression in the pancreas

@en

Interleukin-32 expression in the pancreas

@nl

prefLabel

Interleukin-32 expression in the pancreas

@ast

Interleukin-32 expression in the pancreas

@en

Interleukin-32 expression in the pancreas

@nl

P1433

Q28390023-7A67D8EA-00CD-492C-8561-4B0F2F2E535F

P1476

Q28390023-ADA21167-5B27-4460-8DB7-C53E8C02FDB6

P2093

Q28390023-0186CCFE-E373-4FDC-8523-70FD849906D0

Q28390023-21A9D2BA-13D5-4C75-B21D-BE1E088669A9

Q28390023-B074A74C-8A21-41D4-8C25-3A78CFDBB5C9

Q28390023-C763D982-BA85-42CC-B402-AFCCC04CA7FE

P2860

Q28390023-00C17F6F-362F-4C43-BB36-D656C5A5112A

Q28390023-06367C0C-2C8A-4B13-A78A-E7027E80EADD

Q28390023-15BC5A29-4EDB-41AE-9F08-C8A772551129

Q28390023-1F1E945E-22A1-4F42-A798-8627612AF655

Q28390023-20F9D305-F6D7-4ADA-8423-E9CB15C89DAF

Q28390023-2963C0E4-3F72-4FED-97B5-E8377262A562

Q28390023-298B26E1-D626-4053-AF6E-277EFE6EC052

Q28390023-2F17A16D-97BF-4248-B8A6-0D6C51CF29F0

Q28390023-35E6DE4D-B503-48BD-A06D-8D800C3B12AC

Q28390023-362BF48C-15DE-4908-8F54-F39875B60897

P304

Q28390023-24681D62-60D5-4149-B146-3F25D83E7E0C

P31

Q28390023-BCFF227D-674D-4EA6-8E29-C9B993A0AB79

P3181

Q28390023-DA56ECCD-06D7-44F0-8BE0-F370A640474A

P356

Q28390023-7E38DB21-E471-4A0B-B2A6-5F0716396D7F

P407

Q28390023-F5374467-F667-4B18-AB69-C408F2E849C0

P433

Q28390023-E15DD48D-32C1-4814-8201-D36883E018B6

P478

Q28390023-7BE0D6BE-8C86-41E5-AB4B-F118CCB6F2AF

P577

Q28390023-C53E3F56-14A8-461F-BC89-C14EC0F1FB0D

P698

Q28390023-74FB8D55-6F1C-4009-A7FC-6BC72AAAB97C

P921

Q28390023-76B819C0-53EC-4D21-B1E7-95FF7F0505A4

Q28390023-ECD94645-8A88-4833-80C3-D0C5EC79A1B5

Q28390023-dcf58d64-ef60-4940-9531-8b99d1eb9917

P932

Q28390023-CD75B2F1-D03D-4158-8663-883FEB2325F5

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Interleukin-32 expression in the pancreas

@en

P2093

Akira Andoh

http://www.w3.org/2001/XMLSchema#string

Atsushi Nishida

http://www.w3.org/2001/XMLSchema#string

Osamu Inatomi

http://www.w3.org/2001/XMLSchema#string

Yoshihide Fujiyama

http://www.w3.org/2001/XMLSchema#string

P2860

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

Identification of a novel gene expressed in activated natural killer cells and T cells

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

BID: a novel BH3 domain-only death agonist

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

The Bcl-2 apoptotic switch in cancer development and therapy

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

P304

17868-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1416647

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M900368200

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19386602

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

2719425

http://www.w3.org/2001/XMLSchema#string